Epizyme (EPZM) To Present At Upcoming Conferences In September
8/26/2014 9:54:43 AM
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in five upcoming conferences in September:
•Citi 9th Annual Biotech Conference at the Mandarin Oriental Boston on Wednesday, September 3. Epizyme Chief Executive Officer Robert Gould, Ph.D., will participate in a panel titled “Novel Therapies for Blood Disorders: Making Big Strides vs. Baby Steps” at 2 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by